Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

SELL
$1.76 - $2.83 $70,400 - $113,200
-40,000 Reduced 6.37%
588,218 $1.49 Million
Q3 2023

Oct 25, 2023

SELL
$1.99 - $2.45 $477,600 - $588,000
-240,000 Reduced 27.64%
628,218 $1.5 Million
Q2 2023

Jul 26, 2023

SELL
$2.1 - $3.36 $840,000 - $1.34 Million
-400,000 Reduced 31.54%
868,218 $2.01 Million
Q1 2023

Apr 28, 2023

SELL
$2.13 - $3.6 $260,925 - $441,000
-122,500 Reduced 8.81%
1,268,218 $3.23 Million
Q4 2022

Feb 07, 2023

BUY
$2.05 - $3.47 $57,399 - $97,160
28,000 Added 2.05%
1,390,718 $3.49 Million
Q3 2022

Oct 28, 2022

BUY
$0.63 - $5.47 $24,707 - $214,522
39,218 Added 2.96%
1,362,718 $3.95 Million
Q2 2022

Jul 28, 2022

BUY
$4.27 - $8.26 $742,552 - $1.44 Million
173,900 Added 15.13%
1,323,500 $5.98 Million
Q1 2022

Apr 25, 2022

BUY
$7.07 - $11.62 $813,050 - $1.34 Million
115,000 Added 11.12%
1,149,600 $9.22 Million
Q4 2021

Jan 27, 2022

BUY
$10.49 - $14.28 $7.64 Million - $10.4 Million
728,110 Added 237.56%
1,034,600 $12 Million
Q3 2021

Oct 25, 2021

BUY
$9.94 - $12.77 $3.05 Million - $3.91 Million
306,490 New
306,490 $3.8 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.